Proposed Data Collection Submitted for Public Comment and Recommendations, 70555-70556 [2019-27559]

Download as PDF 70555 Federal Register / Vol. 84, No. 246 / Monday, December 23, 2019 / Notices Findings from MMRCs indicate that more than half of maternal deaths are preventable. Maternal Mortality Review is a process by which a multidisciplinary committee at the jurisdiction level identifies and reviews cases of maternal death within one year of end of pregnancy. Members of MMRCs typically represent public health, obstetrics and gynecology, maternalfetal medicine, nursing, midwifery, forensic pathology, mental and behavioral health, and other relevant stakeholders. Through a partnership among the MMRC, state vital records office, and epidemiologists, deaths among women of reproductive age are examined to determine if they occurred during pregnancy or within one year of the end of pregnancy (i.e., pregnancyassociated deaths). Through this process, potential cases of pregnancyrelated deaths (i.e., maternal death from any cause related to or aggravated by pregnancy or its management) are then identified. Review committees access multiple sources of clinical and nonclinical information to understand the circumstances surrounding a maternal death in order to develop recommendations for action to prevent similar deaths in the future. MMRIA is a standardized data collection system designed to collect timely, accurate, and standardized information about deaths to women during pregnancy and within one year of end of pregnancy, including opportunities for prevention, within and across jurisdictions. Data will be abstracted and entered into MMRIA from various sources, including death certificates, autopsy reports, birth certificates, prenatal care records, emergency room visit records, hospitalization records, records from other medical office visits, medical transport records, social and environmental profiles, mental health profiles, and informant interviews. Case narratives for committee reviews are auto-populated from the abstracted data entered into MMRIA to facilitate committee review, and committee decisions will also be entered into MMRIA. The data collected in MMRIA will be used to facilitate an understanding of the drives of maternal mortality and complications of pregnancy and associated disparities; determine what interventions at patient, provider, facility, system, and community levels will have the most impact; and implement data driven recommendations. The burden estimates presented here are applicable to the estimated 25 awardees of the cooperative agreement Preventing Maternal Deaths: Supporting Maternal Mortality Review Committees (CDC–RFA–DP19–1908); these awardees are required to compile a defined set of information about maternal deaths into MMRIA. It is estimated that information will be collected for a total of 740 pregnancy-associated deaths on average, annually, among the 25 awardees. Burden is estimated based on each awardee’s total staff time to enter the abstracted data into MMRIA and enter the committee decision. The annual burden is estimated to be 11,550 hours. ESTIMATED ANNUALIZED BURDEN HOURS Form name Awardees ........................................................ Data abstraction ............................................. Committee decision ........................................ Jeffery M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2019–27551 Filed 12–20–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60–Day–20–1186; Docket No. CDC–2019– 0098] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: lotter on DSKBCFDHB2PROD with NOTICES Number of respondents Types of respondents The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the SUMMARY: VerDate Sep<11>2014 19:32 Dec 20, 2019 Jkt 250001 general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Information Collection for Tuberculosis Data from Referring Entities to CureTB, which enables CDC to coordinate continuity of care services for individuals with tuberculosis. DATES: CDC must receive written comments on or before February 21, 2020. ADDRESSES: You may submit comments, identified by Docket No. CDC–2019– 0098 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 25 25 Number of responses per respondent Average hours per response (in hours) 30 30 15 24/60 change, all relevant comments to Regulations.gov. Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, of the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS– D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of E:\FR\FM\23DEN1.SGM 23DEN1 70556 Federal Register / Vol. 84, No. 246 / Monday, December 23, 2019 / Notices information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; and 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. 5. Assess information collection costs. Proposed Project Information Collection for Tuberculosis Data from Referring Entities to CureTB (OMB Control No. 0920–1186, Exp. 06/30/2020)— Revision—National Center for Emerging Zoonotic and Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). correctional facilities, and foreign national TB programs. All 50 U.S. states and territories may refer TB patients to the CureTB program. To date, CureTB has also received referrals from Mexico and Guatemala. Registered nurses or nurse practitioners will submit CureTB referral forms as they request referral services. The number of referrals varies widely between respondents. To ensure adequate referral to treatment occurs, CDC CureTB may need to follow-up with an individual to complete missing data fields concerning clinical or contact information. This is done to ensure continuity of care. Therefore, individuals with TB are also respondents in this information collection. CDC’s CureTB program will also continue working with our public health partners in notifications and referrals for contacts of TB cases. This is a lesser used function of CureTB, but burden is included below. These respondents are registered nurses or nurse practitioners working in health departments. Finally, CDC staff in the CureTB program also contact the new treating physicians to determine patient outcomes using CureTB Clinician Public Health Department Follow-up Script. The physicians are generally contacted every two months over the course of standard six month TB treatment, for a total of three follow-up contacts per patient. There are no costs to respondents other than the time required to complete the referral documents and respond to CDC requests for TB patient outcomes. The total burden requested is 1,117 hours. Background and Brief Description CureTB at the Centers for Disease Control and Prevention (CDC), works with domestic and international programs to protect the U.S. public by preventing TB disease transmission domestically and internationally, as well as preventing the development of drug resistant TB. These goals are accomplished through CureTB referral and continuity of care services for mobile TB patients. Lack of treatment adherence and inappropriate selection of medications are prime reasons for the continued emergence and spread of resistant strains of tuberculosis. To combat this, CureTB ensures that patients understand how to remain adherent to treatment regimens, despite moving between nations. CureTB also provides information to the health care team that will be continuing care about each patient’s TB strain and tailored medication regimen. CureTB gathers demographic and clinical information for each patient and connects that individual to appropriate clinical care. This information is also provided on a real-time basis to medical providers and public health authorities in receiving nations so follow-up with the patient can be expedited. The respondents for the CureTB referral services are nurse practitioners, registered nurses, and physicians working for organizations within the United States and other countries who provide diagnostic and treatment services to individuals affected by TB. The organizations are primarily state and local health departments, but include immigration detention centers, ESTIMATED ANNUALIZED BURDEN HOURS Number of responses per respondent Average burden per response (in hours) Total burden hours Form name Registered Nurses/Nurse Practitioners TB patients ........................................... TB patients (ICE referrals) ................... TB treating physicians .......................... CureTB Transnational Notification CureTB Transnational Notification CureTB Transnational Notification Clinician Public Health Department Follow-up Script. CureTB Contact/Source Investigation (CI/SI) Notification. 100 200 600 900 3 1 1 3 30/60 5/60 45/60 10/60 150 17 450 450 20 5 30/60 50 ....................................................... ........................ ........................ ........................ 1,117 Registered Nurses/Nurse Practitioners Total ............................................... lotter on DSKBCFDHB2PROD with NOTICES Number of respondents Type of respondents Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2019–27559 Filed 12–20–19; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 19:32 Dec 20, 2019 Jkt 250001 PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 E:\FR\FM\23DEN1.SGM 23DEN1

Agencies

[Federal Register Volume 84, Number 246 (Monday, December 23, 2019)]
[Notices]
[Pages 70555-70556]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27559]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60-Day-20-1186; Docket No. CDC-2019-0098]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Information Collection for 
Tuberculosis Data from Referring Entities to CureTB, which enables CDC 
to coordinate continuity of care services for individuals with 
tuberculosis.

DATES: CDC must receive written comments on or before February 21, 
2020.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0098 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, of the Information 
Collection Review Office, Centers for Disease Control and Prevention, 
1600 Clifton Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-
7570; Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of

[[Page 70556]]

information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    Information Collection for Tuberculosis Data from Referring 
Entities to CureTB (OMB Control No. 0920-1186, Exp. 06/30/2020)--
Revision--National Center for Emerging Zoonotic and Infectious Diseases 
(NCEZID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    CureTB at the Centers for Disease Control and Prevention (CDC), 
works with domestic and international programs to protect the U.S. 
public by preventing TB disease transmission domestically and 
internationally, as well as preventing the development of drug 
resistant TB. These goals are accomplished through CureTB referral and 
continuity of care services for mobile TB patients.
    Lack of treatment adherence and inappropriate selection of 
medications are prime reasons for the continued emergence and spread of 
resistant strains of tuberculosis. To combat this, CureTB ensures that 
patients understand how to remain adherent to treatment regimens, 
despite moving between nations. CureTB also provides information to the 
health care team that will be continuing care about each patient's TB 
strain and tailored medication regimen. CureTB gathers demographic and 
clinical information for each patient and connects that individual to 
appropriate clinical care. This information is also provided on a real-
time basis to medical providers and public health authorities in 
receiving nations so follow-up with the patient can be expedited.
    The respondents for the CureTB referral services are nurse 
practitioners, registered nurses, and physicians working for 
organizations within the United States and other countries who provide 
diagnostic and treatment services to individuals affected by TB. The 
organizations are primarily state and local health departments, but 
include immigration detention centers, correctional facilities, and 
foreign national TB programs. All 50 U.S. states and territories may 
refer TB patients to the CureTB program. To date, CureTB has also 
received referrals from Mexico and Guatemala.
    Registered nurses or nurse practitioners will submit CureTB 
referral forms as they request referral services. The number of 
referrals varies widely between respondents. To ensure adequate 
referral to treatment occurs, CDC CureTB may need to follow-up with an 
individual to complete missing data fields concerning clinical or 
contact information. This is done to ensure continuity of care. 
Therefore, individuals with TB are also respondents in this information 
collection. CDC's CureTB program will also continue working with our 
public health partners in notifications and referrals for contacts of 
TB cases. This is a lesser used function of CureTB, but burden is 
included below. These respondents are registered nurses or nurse 
practitioners working in health departments.
    Finally, CDC staff in the CureTB program also contact the new 
treating physicians to determine patient outcomes using CureTB 
Clinician Public Health Department Follow-up Script. The physicians are 
generally contacted every two months over the course of standard six 
month TB treatment, for a total of three follow-up contacts per 
patient. There are no costs to respondents other than the time required 
to complete the referral documents and respond to CDC requests for TB 
patient outcomes. The total burden requested is 1,117 hours.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total  burden
     Type of respondents           Form name        respondents   responses  per   response  (in       hours
                                                                     respondent       hours)
----------------------------------------------------------------------------------------------------------------
Registered Nurses/Nurse        CureTB                        100               3           30/60             150
 Practitioners.                 Transnational
                                Notification.
TB patients..................  CureTB                        200               1            5/60              17
                                Transnational
                                Notification.
TB patients (ICE referrals)..  CureTB                        600               1           45/60             450
                                Transnational
                                Notification.
TB treating physicians.......  Clinician Public              900               3           10/60             450
                                Health
                                Department
                                Follow-up Script.
Registered Nurses/Nurse        CureTB Contact/                20               5           30/60              50
 Practitioners.                 Source
                                Investigation
                                (CI/SI)
                                Notification.
                                                 ---------------------------------------------------------------
    Total....................  .................  ..............  ..............  ..............           1,117
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2019-27559 Filed 12-20-19; 8:45 am]
 BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.